In vivo effect of venlafaxine on locus coeruleus neurons: Role of opioid, α2-adrenergic, and 5-hydroxytryptamine1A receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 322, Issue 1, 2007, Pages 101-107

  Berrocoso, Esther ^a   Mico, Juan Antonio ^a,b  

^a UNIVERSITY OF CÁDIZ   (Spain)

^b UNIVERSITY OF CÁDIZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIDEPRESSANT AGENT; IDAZOXAN; NALOXONE; OPIATE; OPIATE ANTAGONIST; SEROTONIN 1A AGONIST; SEROTONIN 1A RECEPTOR; VENLAFAXINE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ELECTROENCEPHALOGRAM; IN VIVO STUDY; LOCUS CERULEUS; MALE; NERVE CELL; NERVE CONDUCTION; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT DURATION;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CYCLOHEXANOLS; IDAZOXAN; LOCUS COERULEUS; MALE; NALOXONE; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, OPIOID; SEROTONIN;

EID: 34250772378     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.107.120915     Document Type: Article

References (42)

1. Aghajanian GK, Cedarbaum JM, and Wang RY (1977) Evidence for norepinephrine-mediated collateral inhibition of locus coeruleus neurons. Brain Res 136:570-577.
2. Béique JC, de Montigny C, Blier P, and Debonnel G (1999) Venlafaxine: discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites. Synapse 32:198-211.
3. Béique J, de Montigny C, Blier P, and Debonnel G (2000a) Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. In vivo electrophysiological studies in the rat. Neuropharmacology 39:1800-1812.
4. Béique J, de Montigny C, Blier P, and Debonnel G (2000b) Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: II. In vitro studies in the rat. Neuropharmacology 39:1813-1822.
5. Berrocoso E, Mico JA, and Ugedo L (2006) In vivo effect of tramadol on locus coeruleus neurons is mediated by alpha2-adrenoceptors and modulated by serotonin. Neuropharmacology 51:146-153.
6. Berrocoso E, Rojas-Corrales MO, and Mico JA (2004) Non-selective opioid receptor antagonism of the antidepressant-like effect of venlafaxine in the forced swimming test in mice. Neurosci Lett 363:25-28.
7. Blier P and de Montigny C (1985) Serotoninergic but not noradrenergic neurons in rat central nervous system adapt to long-term treatment with monoamine oxidase inhibitors. Neuroscience 16:949-955.
8. Crawley JN, Roth RH, and Maas JW (1979) Locus coeruleus stimulation increases noradrenergic metabolite levels in rat spinal cord. Brain Res 166:180-184.
9. Dawson LA, Nguyen HQ, and Geiger A (1999) Effects of venlafaxine on extracellular concentrations of 5-HT and noradrenaline in the rat frontal cortex: augmentation via 5-HT1A receptor antagonism. Neuropharmacology 38:1153-1163.
10. Egan TM, Henderson G, North RA, and Williams JT (1983) Noradrenaline-mediated synaptic inhibition in rat locus coeruleus neurones. J Physiol (Lond) 345:477-488.
11. Freedman JE and Aghajanian GK (1984) Idazoxan (RX 781094) selectively antagonizes alpha 2-adrenoceptors on rat central neurons. Eur J Pharmacol 105:265-272.
12. Gur E, Dremencov E, Lerer B, and Newman ME (1999) Venlafaxine: acute and chronic effects on 5-hydroxytryptamine levels in rat brain in vivo. Eur J Pharmacol 372:17-24.
13. Hamon M, Gozlan H, Bourgoin S, Benoliel JJ, Mauborgne A, Taquet H, Cesselin F, and Mico JA (1987) Opioid receptors and neuropeptides in the CNS in rats treated chronically with amoxapine or amitriptyline. Neuropharmacology 26:531-539.
14. Haskins JT, Moyer JA, Muth EA, and Sigg EB (1985) DMI, Wy-45,030, Wy-45,881 and ciramadol inhibit locus coeruleus neuronal activity. Eur J Pharmacol 115:139-146.
15. Illes P and Norenberg W (1990) Blockade of alpha 2-adrenoceptors increases opioid mu-receptor-mediated inhibition of the firing rate of rat locus coeruleus neurones. Naunyn Schmiedebergs Arch Pharmacol 342:490-496.
16. Isenberg KE and Cicero TJ (1984) Possible involvement of opiate receptors in the pharmacological profiles of antidepressant compounds. Eur J Pharmacol 103:57-63.
17. Jones SL and Gebhart GF (1988) Inhibition of spinal nociceptive transmission from the midbrain, pons and medulla in the rat: activation of descending inhibition by morphine, glutamate and electrical stimulation. Brain Res 460:281-296.
18. Lacroix D, Blier P, Curet O, and de Montigny C (1991) Effects of long-term desipramine administration on noradrenergic neurotransmission: electrophysiological studies in the rat brain. J Pharmacol Exp Ther 257:1081-1090.
19. Linnér L, Arborelius L, Nomikos GG, Bertilsson L, and Svensson TH (1999) Locus coeruleus neuronal activity and noradrenaline availability in the frontal cortex of rats chronically treated with imipramine: effect of alpha 2-adrenoceptor blockade. Biol Psychiatry 46:766-774.
20. Marchand F, Alloui A, Chapuy E, Jourdan D, Pelissier T, Ardid D, Hernandez A, and Eschalier A (2003) Evidence for a monoamine mediated, opioid-independent, antihyperalgesic effect of venlafaxine, a non-tricyclic antidepressant, in a neurogenic pain model in rats. Pain 103:229-235.
21. Marchand F, Pelissier T, Eschalier A, Ardid D, Alloui A, Soto-Moyano R, Mondaca M, Laurido C, Constandil L, and Hernandez A (2004) Blockade of supraspinal 5-HT1A receptors potentiates the inhibitory effect of venlafaxine on wind-up activity in mononeuropathic rats. Brain Res 1008:288-292.
22. Mico JA, Ardid D, Berrocoso E, and Eschalier A (2006) Antidepressants and pain. Trends Pharmacol Sci 27:348-354.
23. Millan MJ, Gobert A, Lejeune F, Newman-Tancredi A, Rivet JM, Auclair A, and Peglion JL (2001) S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine. J Pharmacol Exp Ther 298:565-580.
24. Millan MJ, Lejeune F, and Gobert A (2000) Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents. J Psychopharmacol 14:114-138.
25. Muth EA, Haskins JT, Moyer JA, Husbands GE, Nielsen ST, and Sigg EB (1986) Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative. Biochem Pharmacol 35:4493-4497.
26. Parker RB and Waud DR (1971) Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation. I. Agonists. J Pharmacol Exp Ther 177:1-12.
27. Redrobe JP, Bourin M, Colombel MC, and Baker GB (1998) Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity. Psychopharmacology (Berl) 138:1-8.
28. Rojas-Corrales MO, Ortega-Alvaro A, Gibert-Rahola J, Roca-Vinardell A, and Mico JA (2000) Pindolol, a beta-adrenoceptor blocker/5-hydroxytryptamine(1A/ 1B) antagonist, enhances the analgesic effect of tramadol. Pain 88:119-124.
29. Ruiz-Durántez E, Torrecilla M, Pineda J, and Ugedo L (2003) Attenuation of acute and chronic effects of morphine by the imidazoline receptor ligand 2-(2-benzofuranyl)-2-imidazoline in rat locus coeruleus neurons. Br J Pharmacol 138:494-500.
30. Ruiz-Ortega JA and Ugedo L (1997) Activation of 5-HT1A receptors potentiates the clonidine inhibitory effect in the locus coeruleus. Eur J Pharmacol 333:159-162.
31. Saarto T and Wiffen PJ (2005) Antidepressants for neuropathic pain. Cochrane Database Syst Rev: CD005454.
32. Schreiber S, Backer MM, and Pick CG (1999) The antinociceptive effect of venlafaxine in mice is mediated through opioid and adrenergic mechanisms. Neurosci Lett 273:85-88.
33. Segal M (1979) Serotonergic innervation of the locus coeruleus from the dorsal raphe and its action on responses to noxious stimuli. J Physiol (Lond) 286:401-415.
34. Svensson TH and Usdin T (1978) Feedback inhibition of brain noradrenaline neurons by tricyclic antidepressants: alpha-receptor mediation. Science 202:1089-1091.
35. Szabo ST and Blier P (2001a) Effect of the selective noradrenergic reuptake inhibitor reboxetine on the firing activity of noradrenaline and serotonin neurons. Eur J Neurosci 13:2077-2087.
36. Szabo ST and Blier P (2001b) Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons. Brain Res 922:9-20.
37. Szabo ST and Blier P (2001c) Serotonin (1A) receptor ligands act on norepinephrine neuron firing through excitatory amino acid and GABA(A) receptors: a microiontophoretic study in the rat locus coeruleus. Synapse 42:203-212.
38. Ugedo L, Pineda J, Ruiz-Ortega JA, and Martin-Ruiz R (1998) Stimulation of locus coeruleus neurons by non-I1/I2-type imidazoline receptors: an in vivo and in vitro electrophysiological study. Br J Pharmacol 125:1685-1694.
39. Valentino RJ, Curtis AL, Parris DG, and Wehby RG (1990) Antidepressant actions on brain noradrenergic neurons. J Pharmacol Exp Ther 253:833-840.
40. Valverde O, Mico JA, Maldonado R, Mellado M, and Gibert-Rahola J (1994) Participation of opioid and monoaminergic mechanisms on the antinociceptive effect induced by tricyclic antidepressants in two behavioural pain tests in mice. Prog Neuropsychopharmacol Biol Psychiatry 18:1073-1092.
41. Williams JT and North RA (1984) Opiate-receptor interactions on single locus coeruleus neurones. Mol Pharmacol 26:489-497.
42. Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109-110.